Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control-Reference-Cited by-同舟云学术

Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control

Published:2018-01-31 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Schmid Markus^ORCID,Ernst Patrick^ORCID,Honegger Annemarie^ORCID,Suomalainen Maarit^ORCID,Zimmermann Martina,Braun Lukas,Stauffer Sarah,Thom Cristian^ORCID,Dreier Birgit,Eibauer Matthias,Kipar Anja,Vogel Viola^ORCID,Greber Urs F.^ORCID,Medalia Ohad^ORCID,Plückthun Andreas^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-02707-6.pdf

Reference69 articles.

1. Naldini, L. Gene therapy returns to centre stage. Nature 526, 351–360 (2015).

2. Scott, L. J. Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency. Drugs 75, 175–182 (2015).

3. Ginn, S. L. et al. Gene therapy clinical trials worldwide to 2012 - an update. J. Gene. Med. 15, 65–77 (2013).

4. Abedi, M. R. The Journal of Gene Medicine - Wiley Online Library. Gene therapy trials worldwide. http://www.abedia.com/wiley/vectors.php (accessed on: 06/10/2017).

5. Hendrickx, R. et al. Innate immunity to adenovirus. Hum. Gene. Ther. 25, 265–284 (2014).

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DARPin-fused T cell engager for adenovirus-mediated cancer therapy;Molecular Therapy: Oncology;2024-09

2. The Immune System—A Double-Edged Sword for Adenovirus-Based Therapies;Viruses;2024-06-17

3. Dendritic cell targeting in lymph nodes with engineered modular adapters improves HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21;2024-04-28

4. Gutless Helper-Dependent and First-Generation HAdV5 Vectors Have Similar Mechanical Properties and Common Transduction Mechanisms;Human Gene Therapy;2024-03-01

5. Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy;International Journal of Molecular Sciences;2024-01-18